HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reckitt Extends Children's Mucinex Line In Widening Consumer Strategy

This article was originally published in The Tan Sheet

Executive Summary

Reckitt Benckiser announces a line extension for its Mucinex franchise as the firm prepares for an earlier-than-expected loss of exclusivity for the decongestant product

You may also be interested in...



Amid Growth, Reckitt To Launch Mucinex In Emerging Markets Ahead of EU

Emerging markets, the key driver for Reckitt Benckiser's nearly 20% net income growth, will be crucial in the firm's launch of Mucinex decongestants outside the U.S.

Reckitt Would Add Durex, Scholl Brands With SSL Acquisition

Reckitt Benckiser moves again to grow its consumer products business, particularly in Asian markets, with an offer to acquire Durex condoms and Scholl foot care products manufacturer SSL International

Perrigo Targets October For Quality System Corrections, FDA Re-Inspection

Perrigo wants FDA to re-inspect its Allegan, Mich., manufacturing plant in October, when the private labeler intends to have corrected its quality system failings that elicited a warning letter in April

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135289

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel